Cabg318
发表于 2025-3-25 06:44:30
http://reply.papertrans.cn/83/8298/829765/829765_21.png
过分
发表于 2025-3-25 10:13:48
http://reply.papertrans.cn/83/8298/829765/829765_22.png
约会
发表于 2025-3-25 12:24:12
http://reply.papertrans.cn/83/8298/829765/829765_23.png
热情的我
发表于 2025-3-25 16:45:10
http://reply.papertrans.cn/83/8298/829765/829765_24.png
orthopedist
发表于 2025-3-25 21:31:35
Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders,l fluid (CSF) or blood of patients. These studies have identified possible therapeutic targets and disease biomarkers. Further studies including target validation, the use of large sample sizes, and the integration of omics findings with bioinformatics tools are required to provide a better comprehension of pharmacological targets.
gain631
发表于 2025-3-26 03:47:10
http://reply.papertrans.cn/83/8298/829765/829765_26.png
永久
发表于 2025-3-26 07:08:10
http://reply.papertrans.cn/83/8298/829765/829765_27.png
裂隙
发表于 2025-3-26 10:53:00
,Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer’s Disearapy. Currently, nano-based therapies can make a difference, providing new therapeutic options by helping drugs to cross the blood-brain barrier and enter the brain more effectively. The main aim of this review was to highlight advances in research on the development of nano-based therapeutics for improved treatment of AD.
Truculent
发表于 2025-3-26 15:41:12
http://reply.papertrans.cn/83/8298/829765/829765_29.png
预感
发表于 2025-3-26 17:14:32
Paul C. GuestDescribes potential novel drug targets for age-related disorders.Reviews studies and current research on age-related disorders worldwide.Discusses developments for new therapeutic approaches to age-re